March

March 27, 2015

Immune enhancement therapy: Polyomavirus enhancer activator 3 (PEA3) increases SOX2 expression and promotes innate immunity against bacterial infection, 27/March/2015, 22.47

A recent study from the Key Laboratory of Infection and Immunity, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China shows that “Sox2 functions as a sequence-specific DNA sensor […]
March 27, 2015

MiRNA-based antimetastasis therapy: AMPKα2 inhibits epithelial-mesenchymal transition and cancer cell proliferation via down regulation of GLUT3, 27/March/2015, 22.26

A recent study from the Swiss Institute for Experimental Cancer Research, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, Lausanne 1015, Switzerland shows that “GLUT3 is induced during […]
March 27, 2015

MiRNA-based therapy for pulmonary hypertension: Thioredoxin stifles pulmonary hypertension via down regulation of its target gene, 27/March/2015, 18.16

A recent study from the From the Department of Surgery, University of Pittsburgh Cancer Institute, Division of Pediatric Surgery, Children’s Hospital Pittsburgh, Department of Pharmacology and […]
March 27, 2015

Molecular therapy for Myocardial Infarction: BRCA1 improves ageing- and stress-associated decline in cardiac function via up regulation of PNUTS/PPP1R10 (Serine/threonine-protein phosphatase 1 regulatory subunit 10), 27/March/2015, 08.39 am

A recent study from the Institute for Cardiovascular Regeneration, Centre of Molecular Medicine, Frankfurt, Germany shows that “MicroRNA-34a regulates cardiac ageing and function.” This study was published in the 7 March  2013 issue of Nature  by Prof Dimmler, Boon, and others. On […]